Saturday 17 October 2026 Export ANIP’s income statement to Excel — free account

ANI Pharmaceuticals, Inc.

ANIP Healthcare Drug Manufacturers Specialty & Generic

ANI Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $883.4 million, up 43.8% from fiscal 2024. In the quarter to June 2026, revenue grew 25.9%, EPS grew 194.6%, free cash flow fell 22.2% and total debt fell 1.78%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

72.08 0.20 −0.28%

Follow ANIP

Alert me

Market cap: $1.7B
P/E: 14.9×
Fwd P/E: 14.5×
Dividend yield: —
F-score: 7/9
Altman Z: 2.30
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	53.57	22.55	18.71	17.14
P/S ratio Full definition →		2.22	1.79	1.74	1.79
P/FCF ratio Full definition →		13.59	10.49	8.80	10.46
P/Operating CF Full definition →		41.74	52.13	27.55	30.91
P/B ratio Full definition →		3.64	2.93	2.86	2.93
Price to Tangible BV Full definition →		0.00	0.00	49.24	20.64
EV/Sales Full definition →		2.65	2.16	2.05	2.03
EV/EBITDA Full definition →		12.59	9.41	8.89	8.41
EV/Operating CF Full definition →		12.81	10.29	9.09	10.48
EV/FCF Full definition →		16.17	12.63	10.37	11.86
Quick Ratio Full definition →		1.94	2.07	2.43	2.29
Current Ratio Full definition →		2.58	2.71	3.12	2.91
Net Debt/EBITDA Full definition →		5.92	5.62	4.81	3.90
Debt/Assets Full definition →		44.05%	42.84%	43.16%	40.86%
Debt/Equity Full definition →		1.23	1.14	1.09	1.02
Asset Turnover Full definition →		0.61	0.65	0.68	0.69
Operating CF/Net income Full definition →		1.68	1.10	1.98	2.29
Capex/Depreciation Full definition →		(0.27)	(0.06)	(0.54)	(0.16)
Interest Coverage Full definition →		7.67	7.88	10.32	11.13
Research and Development Expense of Revenue Full definition →		5.40%	4.96%	4.46%	5.54%
Selling, General and Administrative Expense of Revenue Full definition →		33.65%	33.51%	31.02%	34.45%
Intangible Assets out of Total Assets Full definition →		0.40	0.38	0.37	0.34
Share Based Compensation of Revenue Full definition →		4.25%	3.95%	4.29%	4.29%
Graham Net Nets Full definition →		(0.11)	(0.09)	(0.07)	(0.04)
Graham Number Full definition →		31.14	46.08	49.86	55.39
Earnings Yield Full definition →		1.87%	4.43%	5.34%	5.83%
Free Cash Flow Yield Full definition →		7.36%	9.53%	11.37%	9.56%
Revenue per Share Full definition →		11.35	12.32	11.35	12.57
Operating CF per Share Full definition →		2.19	1.51	2.79	2.68
Capex per Share Full definition →		(0.31)	(0.07)	(0.54)	(0.14)
Free Cash Flow per Share Full definition →		1.89	1.44	2.25	2.53
Cash per Share Full definition →		13.53	14.70	15.59	17.77
Shareholders Equity per Share Full definition →		25.20	26.96	26.89	28.23
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		25.20	26.96	26.89	28.23
Free Cash Flow Full definition →		37.89	28.96	47.05	53.62
Working Capital Full definition →		427.85	475.01	507.57	541.78
Capital Expenditures Full definition →		(6.16)	(1.40)	(11.32)	(3.05)
Net Current Asset Value Full definition →		(203.93)	(146.54)	(112.59)	(71.47)
EV/EBIT Full definition →		30.41	17.15	15.32	13.21
Capex to Sales Full definition →		0.03	0.01	0.05	0.01
Price to Operating Income Full definition →		25.56	14.25	12.99	11.65
Other line items
Average Receivables Full definition →		224.49	251.40	237.88	250.06
Average Payables Full definition →		65.34	54.12	61.38	64.20
Average Inventory Full definition →		147.26	139.92	140.44	140.73
Average Assets Full definition →		1,347.76	1,362.42	1,357.20	1,418.56
Average Common Equity Full definition →		455.88	472.20	490.46	516.98

Show all line items

Columns are period end dates

Stockrow Weekly